Results 61 to 70 of about 3,443,048 (342)

The uneven distribution of housing supply 2006–2016

open access: yesAHURI Final Report, 2020
This research examines the quantity, composition and distribution of new housing supply across Australia 2006–16 and seeks to explain variations in local rates of production with reference to demand-side considerations (e.g.
Steven Rowley   +4 more
semanticscholar   +1 more source

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer

open access: yesMolecular Oncology, EarlyView.
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon   +13 more
wiley   +1 more source

Housing supply chain model for innovation: research report [PDF]

open access: yes, 2011
The aim of this research is to undertake a case study analysis of successful delivery of an innovation to the Australian housing construction industry.
Jessica Siva, Kerry London
core  

Time is money: How landbanking constrains housing supply

open access: yesJournal of Housing Economics, 2019
Many housing policies aim to increase supply and reduce prices through rezoning, relying on the assumption that increasing allowable densities automatically accelerates the rate of housing supply.
Cameron K. Murray
semanticscholar   +1 more source

Infrared laser sampling of low volumes combined with shotgun lipidomics reveals lipid markers in palatine tonsil carcinoma

open access: yesMolecular Oncology, EarlyView.
Nanosecond infrared laser (NIRL) low‐volume sampling combined with shotgun lipidomics uncovers distinct lipidome alterations in oropharyngeal squamous cell carcinoma (OPSCC) of the palatine tonsil. Several lipid species consistently differentiate tumor from healthy tissue, highlighting their potential as diagnostic markers.
Leonard Kerkhoff   +11 more
wiley   +1 more source

Absorption Rate as a Tool for Assessing the Dynamics of Development Activity

open access: yesFolia Oeconomica Stetinensia, 2021
Research background: An assessment of the dynamics of the development of the housing market is critical for development activity and the institutions that finance it.
Antczak-Stępniak Agata
doaj   +1 more source

Study on micro-mechanism of the affordable housing community in urban renewal the case of Zunyi city, Guizhou province

open access: yesFrontiers in Environmental Science, 2023
Introduction: Affordable housing in China refers to housing with social security for low and middle income people under the unified planning and coordination of the government.
Qingyan He, Jianzhu Yang, Lei Gong
doaj   +1 more source

The Greater Boston Housing Report Card 2003: An Assessment of Progress on Housing in the Greater Boston Area [PDF]

open access: yes, 2004
Presents an annual survey of the state of housing in Greater Boston: market conditions; housing production; rents, home prices, and affordability; and public spending and support.
Barry Bluestone, Bonnie Heudorfer
core   +2 more sources

Dammarenediol II enhances etoposide‐induced apoptosis by targeting O‐GlcNAc transferase and Akt/GSK3β/mTOR signaling in liver cancer

open access: yesMolecular Oncology, EarlyView.
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee   +8 more
wiley   +1 more source

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

open access: yesMolecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy